Sarajane Ross

Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

Jagath R. Junutula, Helga Raab, Suzanna Clark et al. · Nature Biotechnology · 2008 · 1.3K citations

Medicinal Chemistry, Immunocytochemical Technique, Drug Targeting +10

Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth

Qi Pan, Yvan H. Chanthery, Wei‐Ching Liang et al. · Cancer Cell · 2007 · 527 citations · Full text

Neuro-oncology, Inhibit Tumor Growth, Medicine +11

Kinetic Analysis of Epidermal Growth Factor Receptor Somatic Mutant Proteins Shows Increased Sensitivity to the Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Erlotinib

Kendall D. Carey, Andrew J. Garton, Maria S. Romero et al. · Cancer Research · 2006 · 438 citations

Variants of the Antibody Herceptin That Interact with HER2 and VEGF at the Antigen Binding Site

Jenny Boström, Shang‐Fan Yu, David Kan et al. · Science · 2009 · 362 citations

Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice

Jing Qing, Xiangnan Du, Yongmei Chen et al. · Journal of Clinical Investigation · 2009 · 252 citations · Full text

Bladder Carcinoma, Fgf Receptor 3, Genitourinary Cancer +15